leadf
logo-loader
PINK:THOXF NASDAQ COPENHAG:BIOPO

BioPorto

Receive alerts
Market:
PINK
Market Cap:
$95.22 m
Price
0.40 USD
Change
1.29%
52 weeks high
0.43
52 weeks low
0.39

In brief

BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Our pioneering product portfolio includes assays for underserved disease states such as NGAL for acute kidney injury. We sell our products in more than 80 countries through diverse sales channels and partners. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the Nasdaq Copenhagen stock exchange.

Snapshot

The US-listed Danish company is seeking FDA approval of the NGAL test for use in children and eventually adults